Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease. (Q47990338)
Jump to navigation
Jump to search
scientific article published in September 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease. |
scientific article published in September 2013 |
Statements
1 reference
Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease. (English)
1 reference
Jason W Harper
1 reference
Mika N Sinanan
1 reference
Timothy L Zisman
1 reference
1 September 2013
1 reference
1 reference
19
1 reference
2118-2124
1 reference
10
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference